[1] |
.
[J]. Clinical Focus, 2025, 40(3): 281-284.
|
[2] |
Shi Yujuan, Wang Jing, Xu Ping.
Comparative analysis on pathological results of preoperative & postoperative colorectal intraepithelial neoplasia and early colorectal cancer endoscopic therapies
[J]. Clinical Focus, 2023, 38(1): 55-59.
|
[3] |
Zhang Limin, Sun Jun.
Predictive value of FIB-4 in patients with metabolic-associated fatty liver disease complicated with colorectal adenomatous polyps
[J]. Clinical Focus, 2022, 37(4): 334-338.
|
[4] |
Guo Yanzhen, Wang Nuojin, Ma Junji.
Risk factors for colorectal adenoma
[J]. Clinical Focus, 2022, 37(2): 137-140.
|
[5] |
Song Jie, Wang Jing, Zhang Xiaolan.
The Guidelines for Colorectal Cancer Screening by the American College of Gastroenterology in 2021--an interpretation
[J]. Clinical Focus, 2021, 36(9): 828-831.
|
[6] |
Li Peipei, Cao Yang, Wang Haicun, Dui Weihua.
Effect of Buzhong Yiqi Decoction combined with FOLFIRI chemotherapy on immunity and inflammation in patients with colorectal cancer
[J]. Clinical Focus, 2021, 36(8): 730-734.
|
[7] |
Cao Xiaojing;Song Xiaocui;Du Liyan;Yang Dezhi;Song Xiaoxin;Ma Chao.
Study on Livin and Survivin expression in colorectal cancer and chemotherapy resistance
[J]. Clinical Focus, 2015, 30(8): 891-894.
|
[8] |
He Nana;Cao Hailong;Piao Meiyu;Qi Yanrong;Wang Bangmao.
Clinical,endoscopic and pathological characteristics of young patients with colorectal adenoma
[J]. Clinical Focus, 2015, 30(1): 25-29.
|
[9] |
ZHANG Ke-xin;ZHAO Jie-min;ZOU Yong-yi;WANG Zhi-gang;JIANG Jing-ting.
Clinical observation of FOLFOX4 for postoperative adjuvant chemotherapy on 76 patients with colorectal cancer
[J]. Clinical Focus, 2014, 29(11): 1246-1.24913e+007.
|
[10] |
XU Song-xin;DING Yan-bing;CHEN Yao-sheng;DENG Bin.
Relationship between Helicobacter pylori infection and colorectal neoplasm in eastern countries:a meta-analysis
[J]. Clinical Focus, 2014, 29(8): 877-881.
|
[11] |
.
[J]. Clinical Focus, 2012, 27(7): 593-594617.
|
[12] |
.
[J]. CLINICAL FOCUS, 2009, 24(23): 2105-2107.
|